Back to results
US 2025/0277799 A1Published application
Phospho-tau antibodies and methods of use
AssigneeAlzpath, Inc.
InventorsAndreas Jeromin, Krish Venkat
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods relating to improved assays for establishing Alzheimer's disease. Further provided herein are compositions and methods comprising improved antibodies for assays including immunoassays.
Claims20
A nucleic acid encoding an antibody or antigen-binding fragment that binds to a phosphorylated tau polypeptide, comprising:
- a. a nucleic acid sequence encoding a heavy chain of the antibody or antigen-binding fragment, wherein the heavy chain comprises a variable heavy chain (VH) domain comprising HCDR1 sequence comprising SEQ ID NO:
- 2, HCDR2 sequence comprising SEQ ID NO:
- 7, and HCDR3 sequence comprising SEQ ID NO:
- 11;
- or
- b. a nucleic acid sequence encoding a light chain of the antibody or antigen-binding fragment, wherein the light chain comprises a variable light chain (VL) domain comprising LCDR1 sequence comprising SEQ ID NO:
- 15, LCDR2 sequence comprising SEQ ID NO:
- 21, and LCDR3 sequence comprising SEQ ID NO:
- 25.
6 more elements
Dependencies are inferred from the claim text.